Vasculitis de Churg-Strauss
| Agente | Año | Tipo de estudio | Pacientes (n) | TR (n) | Casos adversos | Recaída | Muertes |
|---|---|---|---|---|---|---|---|
| INFLIXIMAB | 2002 |
D |
1 |
1 |
1 |
0 |
0 |
2004 |
D |
2 |
0 |
0 |
0 |
2 |
|
2005 |
D |
1 |
0 |
0 |
0 |
0 |
|
| Total | 4 |
1 |
1 |
0 |
2 |
||
| RITUXIMAB | 2003 |
C |
15 |
15 |
3 |
5 |
1 |
2003 |
C |
20 |
16 |
3 |
4 |
0 |
|
2004 |
C |
6 |
6 |
0 |
0 |
0 |
|
2006 |
C |
5 |
5 |
0 |
4 |
0 |
|
2006 |
C |
8 |
6 |
0 |
0 |
0 |
|
2007 |
C |
6 |
4 |
0 |
0 |
1 |
|
| Total | 60 |
52 |
6 |
13 |
2 |
||
| % | 86,666667 |
10 |
|||||
2003 |
D |
1 |
1 |
0 |
0 |
0 |
|
2004 |
D |
1 |
1 |
0 |
0 |
0 |
|
2004 |
D |
1 |
1 |
0 |
0 |
0 |
|
2005 |
D |
2 |
0 |
0 |
0 |
0 |
|
2005 |
D |
1 |
1 |
0 |
0 |
0 |
|
2005 |
D |
3 |
3 |
2 |
0 |
1 |
|
2005 |
D |
1 |
0 |
1 |
0 |
0 |
|
2005 |
D |
2 |
1 |
2 |
1 |
0 |
|
2006 |
D |
3 |
3 |
0 |
0 |
0 |
|
2006 |
D |
1 |
1 |
0 |
0 |
0 |
|
2006 |
D |
3 |
3 |
2 |
0 |
1 |
|
2006 |
D |
1 |
0 |
0 |
1 |
1 |
|
2007 |
D |
1 |
1 |
0 |
0 |
0 |
|
2007 |
D |
1 |
1 |
0 |
0 |
0 |
|
2002 |
D |
1 |
1 |
0 |
0 |
0 |
|
2007 |
D |
1 |
1 |
1 |
0 |
0 |
|
2007 |
D |
1 |
1 |
0 |
1 |
1 |
|
2007 |
D |
2 |
2 |
0 |
0 |
0 |
|
2007 |
D |
1 |
1 |
0 |
0 |
0 |
|
| Total | 28 |
23 |
8 |
3 |
4 |
||
| % | 82,142857 |
28,5714286 |
|||||
| ETANERCEPT | 2007 |
D |
6 |
6 |
0 |
0 |
0 |
| Total | 6 |
6 |
0 |
0 |
0 |
||
| ALEMTUZUMAB | 2007 |
D |
1 |
1 |
1 |
0 |
0 |
| Total | 1 |
1 |
1 |
0 |
0 |